Cambridge Investment Research Advisors Inc. Buys 4,588 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Cambridge Investment Research Advisors Inc. grew its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 21.6% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 25,876 shares of the company’s stock after purchasing an additional 4,588 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Bath & Body Works were worth $1,010,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. First Community Trust NA bought a new stake in Bath & Body Works during the 2nd quarter worth approximately $30,000. EverSource Wealth Advisors LLC increased its holdings in Bath & Body Works by 72.0% during the 4th quarter. EverSource Wealth Advisors LLC now owns 805 shares of the company’s stock worth $35,000 after purchasing an additional 337 shares in the last quarter. GAMMA Investing LLC increased its holdings in Bath & Body Works by 75.7% during the 1st quarter. GAMMA Investing LLC now owns 1,116 shares of the company’s stock worth $56,000 after purchasing an additional 481 shares in the last quarter. EntryPoint Capital LLC increased its holdings in Bath & Body Works by 224.0% during the 1st quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock worth $74,000 after purchasing an additional 1,017 shares in the last quarter. Finally, TFO Wealth Partners LLC increased its holdings in Bath & Body Works by 9,664.7% during the 4th quarter. TFO Wealth Partners LLC now owns 1,660 shares of the company’s stock worth $72,000 after purchasing an additional 1,643 shares in the last quarter. 95.14% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Citigroup cut their target price on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 20th. JPMorgan Chase & Co. cut their target price on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a research note on Thursday, August 29th. Piper Sandler cut their target price on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating on the stock in a research note on Thursday, July 11th. BMO Capital Markets restated an “outperform” rating and issued a $50.00 target price (down previously from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. Finally, UBS Group cut their target price on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a research note on Thursday, August 29th. Eight research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, Bath & Body Works presently has an average rating of “Moderate Buy” and an average price target of $43.00.

Bath & Body Works Price Performance

NYSE:BBWI opened at $29.41 on Friday. The company has a market cap of $6.57 billion, a P/E ratio of 7.58, a P/E/G ratio of 1.04 and a beta of 1.85. The stock’s fifty day moving average price is $34.63 and its two-hundred day moving average price is $42.19. Bath & Body Works, Inc. has a 1 year low of $27.30 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Tuesday, June 4th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.05. The firm had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.37 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The business’s quarterly revenue was down .9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.33 earnings per share. On average, analysts expect that Bath & Body Works, Inc. will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 6th. Shareholders of record on Friday, August 23rd will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, August 23rd. This represents a $0.80 annualized dividend and a dividend yield of 2.72%. Bath & Body Works’s dividend payout ratio is currently 20.62%.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.